Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-18 Sale | 2024-11-20 9:31 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 7,246 | $10.78 | $78,112 | 109,885 (Direct) | View |
| 2024-06-07 Sale | 2024-06-10 8:30 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 15,881 | $7.5 | $119,108 | 117,131 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:00 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 6,367 | $6.47 | $41,194 | 133,012 (Direct) | View |
| 2023-11-16 Sale | 2023-11-17 8:01 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 7,313 | $10.92 | $79,858 | 112,714 (Direct) | View |
| 2023-05-16 Sale | 2023-05-18 8:31 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 771 | $18.05 | $13,917 | 120,027 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-01 Option Award | 2024-04-03 8:02 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 106,665 | $0 | 219,379 (Direct) | View |
| 2023-04-01 Option Award | 2023-04-04 8:02 pm | N/A 2033-04-01 | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 125,000 | $0 | 195,798 (Direct) | View |
| 2022-12-01 Option Award | 2022-12-05 8:01 pm | N/A 2032-12-01 | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 43,750 | $0 | 97,048 (Direct) | View |
Ownership | 2022-12-05 8:00 pm | N/A N/A | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 0 | $0 | 138,798 (Direct) | View |